Stoneridge Investment Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Buy
+1,784
New +$1.82M 1.34% 14
2021
Q4
– Sell
-5,450
Closed -$1.26M – 120
2021
Q3
$1.26M Buy
+5,450
New +$1.35M 0.63% 44
2016
Q3
– Sell
-2,953
Closed -$233K – 299
2016
Q2
$233K Buy
+2,953
New +$222K 0.03% 245

Other funds holding LLY

Stoneridge Investment Partners's LLY Position: Q2 2026 in Review

Stoneridge Investment Partners opened a new position in Eli Lilly (LLY) in Q2 2026: 1,784 shares worth $2.05M. The stake represents 1.34% of the portfolio and ranks #14 among its holdings. This is a return to the name: Stoneridge Investment Partners previously reported a position in LLY as recently as Q3 2021.

Stoneridge Investment Partners first reported a position in LLY in Q2 2016 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Stoneridge Investment Partners held 1,784 shares of Eli Lilly worth $2.05M as of Q2 2026.
  • Eli Lilly was a new Stoneridge Investment Partners position in Q2 2026.
  • Eli Lilly made up 1.34% of Stoneridge Investment Partners's portfolio in Q2 2026, its #14 holding.
  • Stoneridge Investment Partners first reported a position in Eli Lilly in Q2 2016 and has held it in 3 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Stoneridge Investment Partners's 13F filing for Q2 2026, filed 6 Aug 2026.